Jim Broderick is the founder of Palleon Pharmaceuticals. Palleon Pharmaceuticals has raised $147M in total funding. Latest round: Series B.
Jim Broderick is the CEO and Founder of Palleon Pharmaceuticals, a company focused on developing drugs targeting glycan-mediated immune regulation to treat cancer and inflammatory diseases. The company has raised a total of $147 million in capital since its inception.
Full founder directory · Investor directory · Company funding database · Fundraising library